Year |
Citation |
Score |
2004 |
McInerney MF, Najjar SM, Brickley D, Lutzke M, Abou-Rjaily GA, Reifsnyder P, Haskell BD, Flurkey K, Zhang YJ, Pietropaolo SL, Pietropaolo M, Byers JP, Leiter EH. Anti-insulin receptor autoantibodies are not required for type 2 diabetes pathogenesis in NZL/Lt mice, a New Zealand obese (NZO)-derived mouse strain. Experimental Diabesity Research. 5: 177-85. PMID 15512785 DOI: 10.1080/15438600490478029 |
0.642 |
|
2004 |
Abou-Rjaily GA, Lee SJ, May D, Al-Share QY, Deangelis AM, Ruch RJ, Neumaier M, Kalthoff H, Lin SH, Najjar SM. CEACAM1 modulates epidermal growth factor receptor--mediated cell proliferation. The Journal of Clinical Investigation. 114: 944-52. PMID 15467833 DOI: 10.1172/JCI21786 |
0.694 |
|
2004 |
Dai T, Abou-Rjaily GA, Al-Share' QY, Yang Y, Fernström MA, Deangelis AM, Lee AD, Sweetman L, Amato A, Pasquali M, Lopaschuk GD, Erickson SK, Najjar SM. Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. The Journal of Biological Chemistry. 279: 45155-61. PMID 15316023 DOI: 10.1074/Jbc.M404764200 |
0.526 |
|
2004 |
Abou-Rjaily GA, Lee SJ, May D, Al-Share QY, DeAngelis AM, Ruch RJ, Neumaier M, Kalthoff H, Lin S, Najjar SM. CEACAM1 modulates epidermal growth factor receptor–mediated cell proliferation Journal of Clinical Investigation. 114: 944-952. DOI: 10.1172/Jci200421786 |
0.679 |
|
2002 |
Fernstrom MJ, Koffler LD, Abou-Rjaily G, Boucher PD, Shewach DS, Ruch RJ. Neoplastic reversal of human ovarian carcinoma cells transfected with connexin43. Experimental and Molecular Pathology. 73: 54-60. PMID 12127054 DOI: 10.1006/Exmp.2002.2436 |
0.33 |
|
Show low-probability matches. |